Acanthocytes in Urine: Glomerular Kidney Disease and Hematuria Meaning

Acanthocytes in urine are abnormally shaped red blood cells that strongly suggest bleeding from the kidney’s glomeruli, the tiny filters that clean the blood. Under the microscope, they look like ring-shaped red cells with one or more irregular membrane blebs or protrusions. They are a specific type of dysmorphic red blood cell and are most useful when a person has microscopic or visible blood in the urine and the source of bleeding is uncertain. Acanthocytes do not identify one exact disease by themselves, but a convincing number can point toward glomerulonephritis or another disorder that damages the glomerular filtration barrier. Their meaning becomes much stronger when they occur with proteinuria, red blood cell casts, reduced kidney function, high blood pressure, or other signs of kidney inflammation. Because red-cell shape changes with collection, urine concentration, and microscopy technique, the result should be interpreted with the rest of the urinalysis and the clinical picture.

• Acanthocytes usually point to glomerular hematuria: they are red blood cells distorted while passing through an injured kidney filtration barrier.
• A commonly used clue is about 5% or more acanthocytes among urinary red cells: this threshold can be highly specific for a glomerular source, although laboratories differ.
• Acanthocytes are more meaningful with proteinuria or RBC casts: the combination raises concern for active glomerular disease.
• A negative result does not rule out glomerular disease: sensitivity varies with timing, specimen quality, and examiner expertise.
• Persistent hematuria needs follow-up: kidney and urologic causes can coexist, so microscopy is one part of the evaluation.

Table of Contents

• What Acanthocytes in Urine Mean
• How Acanthocytes Form and How They Are Identified
• Conditions That Cause Acanthocytes
• How to Interpret Acanthocytes With Other Urine Results
• Testing and Follow-Up After Acanthocytes Are Found
• Limitations, False Reassurance, and Common Mistakes
• When Acanthocytes Need Prompt Medical Attention

What Acanthocytes in Urine Mean

Acanthocytes are one of the strongest urine-microscopy clues that red blood cells entered the urine through damaged glomeruli rather than from the ureter, bladder, prostate, or urethra. The glomerulus is a microscopic capillary network surrounded by a filtration barrier. When that barrier becomes inflamed or structurally damaged, red cells can squeeze through narrow defects, then undergo additional mechanical and osmotic stress as they travel through the nephron. The result is a population of misshapen red cells known as dysmorphic erythrocytes.

An acanthocyte is a particularly recognizable dysmorphic form. It typically has a ring-like body and one or more rounded membrane projections of different sizes. This is different from a uniformly crenated red cell, which may develop multiple evenly spaced spikes when urine is very concentrated or when a specimen sits too long. The distinction matters because crenation can be an artifact, while true acanthocytes support a renal glomerular source of bleeding.

The percentage matters more than the mere presence of one unusual cell. Several classic studies and later reviews have used a threshold around 5% acanthocytes among urinary red blood cells as a strong indicator of glomerular hematuria. Published specificity and positive predictive value for characteristic glomerular red-cell morphology can reach roughly 90% to 100% in experienced hands, but sensitivity is much less consistent. In practical terms, finding a convincing acanthocyte population is useful evidence for glomerular bleeding; failing to find it does not safely exclude glomerular disease.

Acanthocytes should also be separated conceptually from the broader finding of blood on a urine dipstick. A dipstick detects heme and can turn positive because of intact red blood cells, free hemoglobin, or myoglobin. Microscopy confirms whether red cells are actually present and can describe their shape. For readers trying to understand a positive screening result first, a urine blood dipstick result and microscopic red-cell morphology answer different questions.

Microscopic hematuria is usually defined by the number of red cells seen on microscopy rather than by acanthocytes alone. In adults, more than 3 RBCs per high-power field on a properly collected specimen is a widely used threshold for microhematuria. That number says that blood is present; morphology helps localize its source. Someone can therefore meet the definition of microscopic hematuria with 5, 20, or 100 RBCs per field, while the fraction that are acanthocytes provides a separate piece of diagnostic information. The absolute RBC count also fluctuates with hydration and timing, so a trend across well-collected samples may be more informative than one isolated count.

The color of urine is similarly unreliable as a measure of severity. Many people with glomerular disease have urine that looks completely normal because the bleeding is microscopic. Others may have brown, tea-colored, or cola-colored urine during a flare. Bright red urine is often associated with lower urinary tract bleeding, but color alone cannot establish the source. The sediment pattern, protein level, kidney function, and clinical history are more dependable than appearance.

How Acanthocytes Form and How They Are Identified

Acanthocytes are thought to form through a combination of glomerular passage and changing conditions inside the nephron. Red cells that cross an abnormal glomerular basement membrane encounter mechanical deformation, shifts in osmolality, and changes in pH and electrolyte concentration. These stresses alter the cell membrane and produce irregular shapes. Not every red cell becomes an acanthocyte, which is why urine from glomerular disease often contains a mixed population of normal-looking and dysmorphic cells.

Fresh urine gives the best chance of seeing meaningful morphology. Delays can change cell shape, encourage lysis in dilute or alkaline urine, promote crystal formation, and make interpretation harder. Laboratories may examine sediment after centrifugation or use standardized particle-counting methods. Phase-contrast microscopy is especially useful for red-cell morphology because it makes transparent cell outlines easier to see without staining.

The examiner usually evaluates more than one microscopic field and estimates the proportion of acanthocytes among all visible red cells. Some laboratories report “dysmorphic RBCs” without separating acanthocytes; others provide a percentage. There is no single universal reporting standard, so the clinician needs to know the laboratory’s method and cutoff.

Automated urine analyzers can count red blood cells well, but they may be less reliable for complex morphology than expert manual review. If the clinical question is specifically whether hematuria is glomerular, a manual sediment examination may add information that an automated count alone cannot provide. The same issue applies to pathological casts and other subtle sediment findings. A broader urine microscopy examination is therefore more informative than a red-cell count by itself when kidney inflammation is suspected.

Several preanalytic factors can affect the result:

• A sample that sits at room temperature for hours can develop artifacts.
• Very dilute urine may lyse red cells before they are examined.
• Very concentrated urine can alter cell shape.
• Menstrual contamination can add nonglomerular red cells.
• Recent strenuous exercise can cause transient hematuria.
• Collection trauma or urinary instrumentation can introduce fresh, normally shaped red cells.

These factors do not make microscopy useless. They explain why a surprising result may need confirmation with a properly collected fresh specimen.

Conditions That Cause Acanthocytes

Acanthocytes are associated with diseases that disrupt glomerular capillary walls. They do not distinguish one glomerular disorder from another, so the surrounding clinical pattern directs the next steps.

Common or important causes include:

• IgA nephropathy: may cause recurrent visible hematuria, often around respiratory infections, or persistent microscopic hematuria with proteinuria.
• ANCA-associated glomerulonephritis: can cause rapidly declining kidney function, blood and protein in urine, and systemic symptoms related to vasculitis.
• Lupus nephritis: may produce hematuria, proteinuria, cellular casts, and reduced kidney function in people with systemic lupus erythematosus.
• Postinfectious or infection-related glomerulonephritis: can appear after or during infection and may cause edema, hypertension, hematuria, and impaired filtration.
• Alport syndrome and other inherited glomerular basement membrane disorders: can present with persistent hematuria, sometimes beginning in childhood or young adulthood.
• Thin basement membrane–related hematuria: can produce glomerular blood with relatively preserved kidney function, although the underlying genetic and prognostic context varies.
• Other proliferative glomerular diseases: including membranoproliferative patterns and immune-complex disorders.

Acanthocyturia is not the same as a diagnosis of “kidney failure.” Many glomerular diseases are detected while estimated glomerular filtration rate is still normal. Conversely, advanced chronic kidney disease can exist without acanthocytes if there is no active glomerular bleeding at the time of testing.

The finding also does not eliminate urologic causes of hematuria. A person can have glomerular disease and, independently, a stone, infection, enlarged prostate, or urinary tract tumor. Age, smoking history, visible hematuria, urinary symptoms, stone symptoms, and imaging findings still matter. That is why the full evaluation of red blood cells in urine may include both nephrologic and urologic pathways.

How to Interpret Acanthocytes With Other Urine Results

Acanthocytes become more clinically persuasive when other findings point in the same direction. The most useful interpretation is pattern-based rather than focused on one number.

Finding	What it adds	Typical implication
Acanthocytes + proteinuria	Suggests blood and protein are crossing an abnormal glomerular barrier	Stronger concern for glomerular kidney disease
Acanthocytes + RBC casts	RBC casts form inside kidney tubules	Highly supportive of glomerular inflammation
Acanthocytes + rising creatinine	Shows reduced filtration in addition to glomerular bleeding	May require urgent nephrology assessment
Acanthocytes without proteinuria	Still may indicate glomerular bleeding	Repeat testing and clinical correlation are important
Hematuria with mostly normal-shaped RBCs	Provides less support for a glomerular source	Urologic causes may become more likely, but glomerular disease is not excluded

Protein should be quantified rather than judged only by dipstick when glomerular disease is suspected. A urine albumin-to-creatinine ratio or protein-to-creatinine ratio can show how much protein is being lost. The urine albumin-creatinine ratio is particularly useful for detecting and staging albuminuria.

Red blood cell casts are another important clue. A cast is a cylindrical structure formed in the tubules from Tamm-Horsfall protein, also called uromodulin, and embedded particles. When red cells are trapped in that matrix, the result supports bleeding occurring within the nephron rather than lower in the urinary tract. Acanthocytes and red blood cell casts together create a much more convincing glomerular sediment than either an isolated dipstick result or a raw RBC count.

Kidney function provides a separate dimension. Serum creatinine and estimated glomerular filtration rate show how well the kidneys are filtering, not where bleeding originates. A normal eGFR does not cancel out abnormal sediment. Likewise, an abnormal eGFR does not prove that acanthocytes caused or explain the reduced filtration.

Testing and Follow-Up After Acanthocytes Are Found

The next step depends on how much hematuria is present, whether it persists, and what other abnormalities accompany it. A single report in an otherwise well person often leads to repeat urinalysis with a fresh, clean-catch specimen. Persistent acanthocyturia, significant proteinuria, or impaired kidney function deserves a more complete kidney evaluation.

A typical workup may include serum creatinine and eGFR, urine albumin or total protein quantification, blood pressure measurement, and repeat urine sediment. Depending on the pattern, clinicians may order complement levels, antinuclear antibodies, ANCA testing, anti-glomerular basement membrane antibodies, serum immunoglobulins, hepatitis testing, or other targeted studies. These tests are chosen according to symptoms and suspected disease rather than ordered as one universal panel.

Kidney ultrasound may be used to assess kidney size, obstruction, stones, or structural abnormalities. Urologic imaging or cystoscopy may also be appropriate when a person’s age, risk factors, or symptom pattern raises concern for a urinary tract source. The presence of acanthocytes can shift the probability toward a glomerular cause, but it does not automatically replace a risk-based hematuria evaluation.

A kidney biopsy may be considered when there is substantial proteinuria, declining kidney function, a nephritic syndrome, or suspicion of a glomerular disorder for which tissue diagnosis would change treatment. Biopsy is not performed simply because one urine sample contains an acanthocyte.

Blood pressure deserves specific attention because glomerular inflammation can cause sodium retention and raise pressure before a person feels unwell. New edema around the eyes or ankles, rapid weight gain from fluid, and foamy urine can also support a nephritic or nephrotic component. These symptoms are nonspecific, but when they appear together with acanthocytes they make a kidney source more clinically significant. In children and young adults, family history of persistent hematuria, hearing loss, or known inherited kidney disease may shift testing toward genetic causes; in older adults, malignancy risk factors still need a separate urologic assessment.

For persistent abnormalities, clinicians often track trends rather than treating a microscopy percentage as a standalone target. Changes in proteinuria, creatinine, eGFR, blood pressure, and symptoms generally matter more for management than whether the acanthocyte percentage moves from, for example, 8% to 4% on one repeat sample.

Limitations, False Reassurance, and Common Mistakes

The biggest limitation of acanthocyte testing is variability. Red-cell morphology depends on specimen handling, microscope technique, the examiner’s training, and the definition used. Two laboratories can evaluate the same clinical problem using different cutoffs or may simply report “dysmorphic RBCs present.”

One common mistake is assuming that all dysmorphic cells are equally specific. They are not. Acanthocytes are a more distinctive subtype, whereas other irregular shapes can be created by urine osmolality or sample aging. Another mistake is assuming that a small number of acanthocytes proves active glomerulonephritis. Rare atypical cells can be misclassified, so the proportion and the rest of the sediment are important.

The reverse error is more dangerous: assuming that no acanthocytes means no glomerular disease. Sensitivity varies widely. Bleeding may be intermittent, the sample may be too dilute, red cells may have lysed, or the examiner may miss subtle forms. A patient with proteinuria, RBC casts, rising creatinine, edema, or hypertension still needs evaluation even if acanthocytes are not reported.

It is also a mistake to use morphology as a substitute for clinical context. Visible red urine with clots, for example, often suggests a nonglomerular source because clots typically form downstream from the glomeruli, but exceptions and mixed causes occur. Similarly, urinary pain and frequency suggest infection or stone disease, yet these conditions can coexist with kidney disease.

A properly interpreted urinalysis for kidney disease combines chemistry, microscopy, protein assessment, kidney function, and symptoms rather than elevating one finding above all others.

When Acanthocytes Need Prompt Medical Attention

Acanthocytes themselves do not cause symptoms, but the disease producing them can sometimes progress quickly. Prompt medical assessment is important when hematuria occurs with a noticeable fall in urine output, new swelling, shortness of breath, severe or rapidly rising blood pressure, marked weakness, or worsening kidney function. Visible blood in the urine that is heavy, recurrent, or accompanied by clots also deserves timely evaluation even if a previous microscopy report suggested a glomerular source.

More urgent kidney assessment is warranted when the urine sediment shows acanthocytes together with RBC casts and substantial proteinuria, especially if serum creatinine is rising over days to weeks. That pattern can occur in rapidly progressive glomerulonephritis, where early diagnosis can affect kidney recovery.

For people who feel well and have stable kidney function, the finding is usually handled through organized outpatient follow-up rather than emergency care. The key is not to ignore persistent hematuria. Repeat testing should confirm whether the abnormality remains, and the workup should determine whether the bleeding is glomerular, urologic, or occasionally a combination of both.

References

• Glomerular Hematuria and the Utility of Urine Microscopy: A Review 2022 (Review)
• The EFLM European Urinalysis Guideline 2023 2024 (Guideline)
• An updated approach to the evaluation of the urinary sediment 2025 (Review)
• Glomerular Hematuria for the Diagnosis of Glomerulonephritis. 2025
• Recommendations for optimizing the use of dysmorphic red blood cell counts in the clinical laboratory 2026 (Position Statement)

Disclaimer

Acanthocytes are a laboratory clue, not a diagnosis by themselves. Persistent hematuria, proteinuria, abnormal kidney function, or symptoms suggesting kidney inflammation should be reviewed by a qualified clinician, who can decide whether repeat microscopy, blood tests, imaging, nephrology referral, or urologic evaluation is needed.